 In the late 1980s, during further development of NRTIs, the field of NNRTIs discovery began.The development of NNRTIs improved quickly into the 1990s and they soon became the third class of antiretroviral drugs, following the protease inhibitors.The NNRTIs are HIV-1 specific and have no activity against HIV-2 and other retroviruses.